Abstract:

Regulating the treatment of rifampicin-sensitive tuberculosis and improving the quality of treatment are crucial for the prevention and treatment of drug-resistant tuberculosis and the control of the tuberculosis epidemic. First of all, attach importance to etiological examination, choose suitable auxiliary examination in combination with the condition of tuberculosis patients, and use the corresponding treatment plan according to the type of tuberculosis; second, first-line anti-tuberculosis drugs are preferred, patients without gastrointestinal absorption dysfunction should take oral drugs for the whole course of treatment; third, use standard anti-tuberculosis treatment plan, that is, using H-R-Z-E in the intensive period and taking sufficiently, it is recommended to use anti-tuberculosis fixed-dose combination (FDC) for anti-tuberculosis treatment; fourth, etiological examination is the gold standard for judging the efficacy of anti-tuberculosis treatment, objectively evaluating the therapeutic effect of patients. The patients who completing the course of anti-tuberculosis treatment and meeting with the treatment success standard, can stop anti-tuberculous treatment.

Key words: Tuberculosis, Program evaluation, Antitubercular agents, Treatment outcome